However, this study [26] utilized a panel consisting of BRCA1/2, PALB2, CHEK2, and ATM only, whereas the GRACE panel was more extensive and included genes not traditionally associated with ovarian cancer, which explains our higher prevalence of P/LP variants overall. The gene discussed is CHEK2; the disease is ovarian carcinoma.